Complete vs Culprit Lesion–Only Revascularization for STEMI
JAMA Cardiology-JUNE 2020
TAKE-HOME MESSAGE
The authors of this meta-analysis of 10 randomized trials, 7030 patients, evaluated the association between complete revascularization of the nonculprit lesion among patients with STEMI and the risk of cardiovascular (CV) mortality.
After a mean follow-up of 29.5 months, complete revascularization was associated with reduced CV mortality compared with culprit lesion–only PCI.
The use of a fractional flow reserve (FFR)–guided strategy or an angiography-guided strategy did not impact the association between complete revascularization and the reduced risk of CV death.
Complete revascularization was associated with a reduced risk of CV mortality compared with culprit lesion–only PCI in patients with STEMI using either an FFR- or angiography-guided strategy.
FULL ABSTRACT AVAILABLE FROM AUTHOR ON REQUEST